Literature DB >> 23591756

Diagnostic criteria for pediatric multiple sclerosis.

Jennifer P Rubin1, Nancy L Kuntz.   

Abstract

An estimated 2 % to 5 % of all persons with multiple sclerosis (MS) have onset of symptoms before 16 years of age Krupp and Hertz (Neurology 68(Suppl 2), 2007). As in adults, the diagnosis of pediatric MS is a clinical one, requiring recurrent episodes of CNS demyelination with supportive paraclinical data (MRI findings, CSF characteristics) in the absence of another plausible diagnosis. The differential diagnosis is broad and, the more atypical the case and the younger the child, the more consideration is necessary before making a diagnosis of MS. MS must be differentiated from acute disseminated encephalomyelitis (ADEM) or neuromyelitis optica (NMO). After initial presentation with a CNS demyelinating event or clinically isolated syndrome (CIS), children can meet the diagnostic criteria for MS if serial changes are noted on MRI and other disorders are excluded. Accurate diagnosis of pediatric MS is critical because of the implications of the diagnosis, including the need for long-term disease modifying therapy.

Entities:  

Mesh:

Year:  2013        PMID: 23591756     DOI: 10.1007/s11910-013-0354-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  33 in total

1.  Lyme disease of the CNS: MR imaging findings in 14 cases.

Authors:  R E Fernandez; M Rothberg; G Ferencz; D Wujack
Journal:  AJNR Am J Neuroradiol       Date:  1990-05       Impact factor: 3.825

Review 2.  Challenges in the classification of pediatric multiple sclerosis and future directions.

Authors:  Anita L Belman; Tanuja Chitnis; Christel Renoux; Emmanuelle Waubant
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

Review 3.  Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment.

Authors:  Ali Duzova; Aysin Bakkaloglu
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

4.  Pediatric multiple sclerosis.

Authors:  Tanuja Chitnis; Lauren Krupp; Ann Yeh; Jennifer Rubin; Nancy Kuntz; Jonathan B Strober; Dorothee Chabas; Bianca Weinstock-Guttmann; Jayne Ness; Moses Rodriguez; Emmanuelle Waubant
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

5.  Early diagnosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): the role of MRI.

Authors:  Francesco Fattapposta; Rita Restuccia; Cristina Pirro; Alessandro Malandrini; Nicoletta Locuratolo; Giuseppe Amabile; Federico Bianco
Journal:  Funct Neurol       Date:  2004 Oct-Dec

Review 6.  Acute disseminated encephalomyelitis.

Authors:  Silvia Tenembaum; Tanuja Chitnis; Jayne Ness; Jin S Hahn
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

Review 7.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

8.  Phenotypic variation in leukoencephalopathy with vanishing white matter.

Authors:  M S van der Knaap; W Kamphorst; P G Barth; C L Kraaijeveld; E Gut; J Valk
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

Review 9.  Mycoplasma pneumoniae ecephalitis.

Authors:  Ari Bitnun; Elizabeth Ford-Jones; Susan Blaser; Susan Richardson
Journal:  Semin Pediatr Infect Dis       Date:  2003-04

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  5 in total

1.  Prognostic Factors of MS Conversion in Optic Neuritis.

Authors:  Marytery Fajardo; Jennifer P Rubin
Journal:  Pediatr Neurol Briefs       Date:  2015-06

Review 2.  Pediatric multiple sclerosis: a review.

Authors:  Raed Alroughani; Alexey Boyko
Journal:  BMC Neurol       Date:  2018-03-09       Impact factor: 2.474

3.  Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.

Authors:  Calvin Chi; Xiaorong Shao; Brooke Rhead; Edlin Gonzales; Jessica B Smith; Anny H Xiang; Jennifer Graves; Amy Waldman; Timothy Lotze; Teri Schreiner; Bianca Weinstock-Guttman; Gregory Aaen; Jan-Mendelt Tillema; Jayne Ness; Meghan Candee; Lauren Krupp; Mark Gorman; Leslie Benson; Tanuja Chitnis; Soe Mar; Anita Belman; Theron Charles Casper; John Rose; Manikum Moodley; Mary Rensel; Moses Rodriguez; Benjamin Greenberg; Llana Kahn; Jennifer Rubin; Catherine Schaefer; Emmanuelle Waubant; Annette Langer-Gould; Lisa F Barcellos
Journal:  PLoS Genet       Date:  2019-01-17       Impact factor: 5.917

4.  Acquired demyelinating disorders of central nervous system: A pediatric cohort.

Authors:  Sheffali Gulati; Biswaroop Chakrabarty; Atin Kumar; Puneet Jain; Harsh Patel; Lokesh Saini
Journal:  Ann Indian Acad Neurol       Date:  2015-09       Impact factor: 1.383

Review 5.  Differential diagnosis of multiple sclerosis in Latin America.

Authors:  Y D Fragoso; F G Elso; A Carrá
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.